Prostate cancer surgery more costly for obese men (Reuters)
Wednesday, April 7th, 2010Reuters – Being obese may increase the cost of surgery for men with prostate cancer — at least the more traditional forms of the procedure, a new study suggests.
| Male Orgasm Pills |
| Pills to help men achieve greatness |
Reuters – Being obese may increase the cost of surgery for men with prostate cancer — at least the more traditional forms of the procedure, a new study suggests.
Reuters – Despite the popularity of robot-assisted procedures for prostate cancer, when it comes to men’s long-term quality of life, patients with earlier stage cancers generally fare better with non-surgical approaches than with surgery, according to a new study.
AP – Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use.
AFP – A drug commonly used to shrink enlarged prostates in men has been found to also cut the risk of developing cancer in the same glands, a new study said.
AFP – A drug commonly used to shrink enlarged prostates in men has been found to also cut the risk of developing cancer in the same glands, a new study said.
Reuters – Experts generally recommend against routinely using PSA blood tests to screen elderly men for prostate cancer, but using a strict age cutoff for when to stop screening may not be the best route either, a new study suggests.
Reuters – “Watchful waiting” for disease progression won’t make men with slow-growing prostate cancer more anxious or distressed, especially if they’re in relatively good health otherwise and not too anxious to begin with, new research shows.
HealthDay – MONDAY, March 22 (HealthDay News) — Infertility increases the
risk that a man will develop the aggressive, potentially fatal form of
prostate cancer, a new study suggests.
Reuters – Infertile men may have an increased risk of developing aggressive prostate cancer, researchers reported on Monday in what could be an important move toward identifying those who will benefit from screening for the disease.